Donor-derived equine mesenchymal stem cells suppress proliferation of mismatched lymphocytes.

B RaneraD AntczakD MillerT DoroshenkovaA RyanC W McIlwraithFrank Barry

Published in: Equine veterinary journal (2015)

The results demonstrate dose-dependent immunosuppression of stimulated lymphocytes by mismatched equine BM-MSCs, supporting their future application in allo-MSC clinical treatments.

Keyphrases

mesenchymal stem cells
peripheral blood
umbilical cord
bone marrow
signaling pathway
current status
cell therapy
stem cells